Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre
- 1 January 2007
- journal article
- research article
- Published by CSIRO Publishing in Sexual Health
- Vol. 4 (1) , 27-30
- https://doi.org/10.1071/sh06008
Abstract
Background: In Australia, rates of hepatitis B (HBV) transmission continue to be higher in certain populations, including commercial sex workers and injecting drug users (IDU). This study aims to identify rates and predictors of completion of a HBV vaccination schedule in ‘high-risk’ attendees of a primary health care centre in Sydney. Methods: All clients who attended Kirketon Road Centre, a primary health care centre located in Kings Cross, Sydney, with no evidence of HBV immunity were included in the cohort. The study design was observational with historical controls. The main outcome measure was completion of a three-dose HBV vaccine schedule in the study period. Results: Among 2085 clients who received a first vaccination, 1013 (49%) received a second and 435 (21%) received a third vaccination. Univariate analysis found that significant predictors of completion of the vaccine schedule were intention to administer an accelerated schedule (OR 1.49, P = 0.004), not being an IDU (OR 1.29, P = 0.02) and shorter time between first visit and first vaccine dose (OR 1.24, P for trendKeywords
This publication has 16 references indexed in Scilit:
- An accelerated hepatitis B vaccination schedule for young drug usersAustralian and New Zealand Journal of Public Health, 2005
- Occult hepatitis B virus infection in a North American adult hemodialysis patient populationHepatology, 2004
- Hepatitis C Virus in the Setting of HIV or Hepatitis B Virus CoinfectionSeminars in Liver Disease, 2004
- Estimates of chronic hepatitis B virus infection in Australia, 2000Australian and New Zealand Journal of Public Health, 2004
- A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug usersDrug and Alcohol Dependence, 2003
- The impact of reducing dose frequency on health outcomesClinical Therapeutics, 2003
- Immunogenicity of 10 and 20 μg hepatitis B vaccine in a two-dose scheduleVaccine, 2003
- Risk factors for hepatitis C virus infection among injecting drug users in Sydney.Sexually Transmitted Infections, 1994
- Three-week hepatitis B vaccination provides protective immunityVaccine, 1993
- Early anti-HBs antibody response to accelerated and to conventional hepatitis B vaccination regimens in healthy personsJournal of Infection, 1991